Clinical study of safety and efficacy of DMA110 topical gel in the treatment of genital wart.

Clinical study of safety and efficacy of DMA110 topical gel in the treatment of genital wart from Papillomavirus.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181026041466N6

Enrollment

Registered

2021-05-25

Start date

2021-05-20

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital wart. Anogenital (venereal) warts

Interventions

Intervention 1: Intervention group: DMA110 Herbal topical gel made by Ryka pharmaceutical co containing Green tea and garlic extract. taking 2-3 times a day on all warts until Complete removal of les

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with genital warts

Exclusion criteria

Exclusion criteria: Patients who need to take immune suppressive drugs such as corticosteroids , chemotheraputic drugs or undergoing radiation therapy. Patients suffering from immune deficiency-associated diseases such as diabetes, cancer, HIV. pregnancy lactation A wound or active skin disease other than wart at the treatment site

Design outcomes

Primary

Measure	Time frame
Side effects from treatment. Timepoint: In 7, 14, 21, 28, 35, 42, 49, 56, 84, 112, 140, 168, 196 and 238 days. Method of measurement: Inspection and clinical examination, Patients' complaints.;Measurement of genital wart size. Timepoint: In 0, 7, 14, 21, 28, 35, 42, 49, 56, 84, 112, 140, 168, 196 and 238 days. Method of measurement: caliper.;Number of warts. Timepoint: In 0, 7, 14, 21, 28, 35, 42, 49, 56, 84, 112, 140, 168, 196 and 238 days. Method of measurement: Clinical counting.	—

Measure

Time frame

Side effects from treatment. Timepoint: In 7, 14, 21, 28, 35, 42, 49, 56, 84, 112, 140, 168, 196 and 238 days. Method of measurement: Inspection and clinical examination, Patients' complaints.;Measurement of genital wart size. Timepoint: In 0, 7, 14, 21, 28, 35, 42, 49, 56, 84, 112, 140, 168, 196 and 238 days. Method of measurement: caliper.;Number of warts. Timepoint: In 0, 7, 14, 21, 28, 35, 42, 49, 56, 84, 112, 140, 168, 196 and 238 days. Method of measurement: Clinical counting.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Malayeri

Ahvaz University of Medical Sciences

malayeri.a@ajums.ac.ir+98 61 3334 2197

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026